Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07230964 · ClinicalTrials.gov registry record · NA
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
A NA study of Aortic Stenosis, sponsored by Dermed Diagnostics.
- Recruiting
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT07230964: Recruiting NA study of Aortic Stenosis, sponsored by Dermed Diagnostics.
NCT07230964 is a NA study of Aortic Stenosis that is actively recruiting participants, run by Dermed Diagnostics. The registered enrollment target is 6 participants, below the 1,362-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07230964, a NA study of Aortic Stenosis, is actively recruiting participants, sponsored by Dermed Diagnostics.
- RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness of impedance cardiography (ICG), the HYPERGRAPH test, in detecting left ventricular decompensation in patients with aortic stenosis, compared to cardiac magnetic resonance (CMR) imaging findings. The study aims to obtain usable ICG test data on six patients with aortic stenosis who have recently undergone CMR scans with late gadolinium enhancement, and who do not have a history of myocardial infarction or cardiac amyloidosis. The hypothesis to be tested is that the HYPERGRAPH can accurately detect left ventricular decompensation associated with replacement fibrosis obtained from CMR imaging.
Primary Outcome
Look for a negative ICG test for decompensation correlating with a CMR scan indicating a very low extracellular volume and a positive ICG test for decompensation correlating with a CMR scan indicating a very high extracellular volume.
Conditions Studied
Interventions
- DEVICE Impedance Cardiography Upright/Supine Test
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-11-10 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What NCT07230964 shows while recruiting
NCT07230964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,362-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Impedance Cardiography Upright/Supine Test is the first listed.
NCT07230964 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07230964 about?
NCT07230964 is a clinical study titled "Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis". The purpose of this study is to evaluate the effectiveness of impedance cardiography (ICG), the HYPERGRAPH test, in detecting left ventricular decompensation in patients with aortic stenosis, compared to cardiac magnetic resonance (CMR) imaging findings. The study aims to obtain usable ICG test data...
What is the current status of trial NCT07230964?
This trial is currently recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2025-11-10. Estimated completion is 2026-11-30.
What conditions does trial NCT07230964 study?
This clinical trial studies the following conditions: Aortic Stenosis.
What interventions are being tested in trial NCT07230964?
The interventions under investigation include: Impedance Cardiography Upright/Supine Test (DEVICE).
Who is sponsoring clinical trial NCT07230964?
This trial is sponsored by Dermed Diagnostics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07230964 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07230964's enrollment target sits among peer trials
6 26th of 26 higher than 1 of 26 other Aortic Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
RECRUITING · NA
-
PARTNER 3 Trial - Aortic Valve-in-Valve
RECRUITING · NA
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
-
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI